These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 21436127)
1. Oversulfated chondroitin sulfate and OSCS-contaminated heparin cause dose- and route-dependent hemodynamic effects in the rat. Corbier A; Le Berre N; Rampe D; Meng H; Lorenz M; Vicat P; Potdevin S; Doubovetzky M Toxicol Sci; 2011 Jun; 121(2):417-27. PubMed ID: 21436127 [TBL] [Abstract][Full Text] [Related]
2. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin. McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614 [TBL] [Abstract][Full Text] [Related]
3. Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products. Bairstow S; McKee J; Nordhaus M; Johnson R Anal Biochem; 2009 May; 388(2):317-21. PubMed ID: 19289093 [TBL] [Abstract][Full Text] [Related]
4. Contaminated heparin associated with adverse clinical events and activation of the contact system. Kishimoto TK; Viswanathan K; Ganguly T; Elankumaran S; Smith S; Pelzer K; Lansing JC; Sriranganathan N; Zhao G; Galcheva-Gargova Z; Al-Hakim A; Bailey GS; Fraser B; Roy S; Rogers-Cotrone T; Buhse L; Whary M; Fox J; Nasr M; Dal Pan GJ; Shriver Z; Langer RS; Venkataraman G; Austen KF; Woodcock J; Sasisekharan R N Engl J Med; 2008 Jun; 358(23):2457-67. PubMed ID: 18434646 [TBL] [Abstract][Full Text] [Related]
5. [Anaphylactoid reactions associated with contaminated heparin from China]. Montpas N; Désormeaux A; Keire D; Adam A Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126 [TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate. Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698 [TBL] [Abstract][Full Text] [Related]
7. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin. Gray A; Litinas E; Jeske W; Fareed J; Hoppensteadt D Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630 [TBL] [Abstract][Full Text] [Related]
8. Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro. Adam A; Montpas N; Keire D; Désormeaux A; Brown NJ; Marceau F; Westenberger B Biomaterials; 2010 Aug; 31(22):5741-8. PubMed ID: 20427081 [TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin. Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248 [TBL] [Abstract][Full Text] [Related]
10. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis. Somsen GW; Tak YH; Toraño JS; Jongen PM; de Jong GJ J Chromatogr A; 2009 May; 1216(18):4107-12. PubMed ID: 19272607 [TBL] [Abstract][Full Text] [Related]
11. The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system. Hogwood J; Naggi A; Torri G; Page C; Rigsby P; Mulloy B; Gray E PLoS One; 2018; 13(3):e0193482. PubMed ID: 29494632 [TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin. Adiguzel C; Bansal V; Litinas E; Cunanan J; Iqbal O; Nelson K; Kannan M; Hoppensteadt D; Fareed J Clin Appl Thromb Hemost; 2009; 15(2):145-51. PubMed ID: 19357103 [TBL] [Abstract][Full Text] [Related]
13. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Warkentin TE; Greinacher A Expert Opin Drug Saf; 2009 Mar; 8(2):129-44. PubMed ID: 19309242 [TBL] [Abstract][Full Text] [Related]
14. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants. Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547 [TBL] [Abstract][Full Text] [Related]
15. Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008. McMahon AW; Pratt RG; Hammad TA; Kozlowski S; Zhou E; Lu S; Kulick CG; Mallick T; Dal Pan G Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):921-33. PubMed ID: 20661880 [TBL] [Abstract][Full Text] [Related]
17. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins. Li B; Suwan J; Martin JG; Zhang F; Zhang Z; Hoppensteadt D; Clark M; Fareed J; Linhardt RJ Biochem Pharmacol; 2009 Aug; 78(3):292-300. PubMed ID: 19389385 [TBL] [Abstract][Full Text] [Related]
18. Sensitive detection of oversulfated chondroitin sulfate in heparin sodium or crude heparin with a colorimetric microplate based assay. Sommers CD; Mans DJ; Mecker LC; Keire DA Anal Chem; 2011 May; 83(9):3422-30. PubMed ID: 21449571 [TBL] [Abstract][Full Text] [Related]
19. Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography. Hashii N; Kawasaki N; Itoh S; Qin Y; Fujita N; Hattori T; Miyata K; Bando A; Sekimoto Y; Hama T; Kashimura M; Tatsumi M; Mabuchi K; Namekawa H; Sakai T; Hirose M; Dobashi S; Shimahashi H; Koyama S; Herr SO; Kawai K; Yoden H; Yamaguchi T Biologicals; 2010 Sep; 38(5):539-43. PubMed ID: 20452241 [TBL] [Abstract][Full Text] [Related]
20. Case study: contamination of heparin with oversulfated chondroitin sulfate. Chess EK; Bairstow S; Donovan S; Havel K; Hu P; Johnson RJ; Lee S; McKee J; Miller R; Moore E; Nordhaus M; Ray J; Szabo C; Wielgos T Handb Exp Pharmacol; 2012; (207):99-125. PubMed ID: 22566223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]